GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hemo Organic Ltd (BOM:524590) » Definitions » EV-to-FCF

Hemo Organic (BOM:524590) EV-to-FCF : (As of May. 01, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Hemo Organic EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hemo Organic's Enterprise Value is ₹42.45 Mil. Hemo Organic's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00 Mil. Therefore, Hemo Organic's EV-to-FCF for today is .

The historical rank and industry rank for Hemo Organic's EV-to-FCF or its related term are showing as below:

BOM:524590' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 39.14
Current: 39.01

During the past 13 years, the highest EV-to-FCF of Hemo Organic was 39.14. The lowest was 0.00. And the median was 0.00.

BOM:524590's EV-to-FCF is ranked worse than
67.06% of 510 companies
in the Drug Manufacturers industry
Industry Median: 22.655 vs BOM:524590: 39.01

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-01), Hemo Organic's stock price is ₹12.32. Hemo Organic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-0.310. Therefore, Hemo Organic's PE Ratio for today is At Loss.


Hemo Organic EV-to-FCF Historical Data

The historical data trend for Hemo Organic's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemo Organic EV-to-FCF Chart

Hemo Organic Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -133.87 665.84 -368.23 -4,046.79 22.15

Hemo Organic Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 22.15 - - -

Competitive Comparison of Hemo Organic's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Hemo Organic's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemo Organic's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hemo Organic's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Hemo Organic's EV-to-FCF falls into.



Hemo Organic EV-to-FCF Calculation

Hemo Organic's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=42.447/0
=

Hemo Organic's current Enterprise Value is ₹42.45 Mil.
Hemo Organic's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hemo Organic  (BOM:524590) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hemo Organic's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=12.32/-0.310
=At Loss

Hemo Organic's share price for today is ₹12.32.
Hemo Organic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.310.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Hemo Organic EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Hemo Organic's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemo Organic (BOM:524590) Business Description

Traded in Other Exchanges
N/A
Address
V V Nagar Road, 8-A, Gulnar, Chinar - Gulnar Appartment, Anand, GJ, IND, 388001
Hemo Organic Ltd is an India based company principally engaged in the business activity of manufacturing of ayurvedic or unani pharmaceutical preparation. It generates revenue by primarily selling its ayurvedic or unani pharmaceutical products.

Hemo Organic (BOM:524590) Headlines

No Headlines